Literature DB >> 1802703

Susceptibility of Helicobacter pylori to metronidazole.

M López-Brea, E Martín, C López-Lavid, J C Sanz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1802703     DOI： 10.1007/BF01984937

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  In vitro selection of resistant Helicobacter pylori.

Authors:  C E Haas; D E Nix; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

2.  Metronidazole resistance in Helicobacter pylori.

Authors:  Y Glupczynski; A Burette; E De Koster; J F Nyst; M Deltenre; S Cadranel; L Bourdeaux; D De Vos
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

3.  Metronidazole-resistant Helicobacter pylori.

Authors:  M C Becx; A J Janssen; H A Clasener; R W de Koning
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

4.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

Review 5.  Campylobacter pylori.

Authors:  G N Tytgat; E A Rauws; E De Koster
Journal:  Scand J Gastroenterol Suppl       Date:  1988

6.  Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.

Authors:  C A McNulty; J Dent; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

7.  Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Authors:  C S Goodwin; B J Marshall; E D Blincow; D H Wilson; S Blackbourn; M Phillips
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

8.  Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.

Authors:  C A McNulty; J C Dent
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

Review 9.  Campylobacter pylori--therapy review.

Authors:  A T Axon
Journal:  Scand J Gastroenterol Suppl       Date:  1989

10.  Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens.

Authors:  Y Glupczynski; A Burette; J F Nyst; C De Prez; E De Koster; M Deltenre
Journal:  Acta Gastroenterol Belg       Date:  1988 Jul-Oct       Impact factor: 1.316
  10 in total
  1 in total

Review 1.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.